|
시장보고서
상품코드
2042656
심내막심근 생검 기기 시장 규모 및 예측(2021-2034년), 세계 및 지역별 점유율, 동향, 성장 기회 분석 보고서 : 제품 유형별, 가이드 기법별, 용도별, 최종사용자별, 지역별Endomyocardial Biopsy Devices Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product Type, Guidance Technique, Application, End User, and Geography |
||||||
새로운 조사 보고서 "심내막심근 생검 기기 시장 규모 및 예측(2021-2034) - 제품 유형, 가이드 기술, 용도, 최종사용자, 지역별 세계 분석"에 따르면 시장 규모는 2025년 3억 5,225만 달러에서 2034년에는 5억 1만 달러로 확대될 것으로 예상되며, 2026년부터 2034년까지의 연평균 성장률(CAGR)은 4.0%에 달할 것으로 전망됩니다. 심내막심근 생검 기기 시장의 성장은 심장 이식 수술 건수 증가, 심혈관질환(CVD) 유병률 증가, 생검 겸자 및 카테터 설계의 기술적 진보에 기인합니다.
심내막심근 생검(EMB) 기기는 주로 심근염, 심근증, 이식 거부 반응 및 기타 심장 질환의 진단을 목적으로 심장 조직 샘플을 채취하는 데 사용됩니다. 주요 제품으로는 생검 집게, 플렉시블 카테터, 일회용 또는 재사용 가능한 디자인의 제품이 있으며, 이들은 투시 검사, 심초음파 검사, 또는 정확도를 높이기 위한 새로운 로봇 내비게이션과 같은 유도 시스템과 함께 사용됩니다. 인트로듀서 시스, 가이드 와이어, 위치 결정 도구 등의 부속품이 이 시술을 지원합니다. 주요 최종 사용자는 심장 센터, 병원, 진단 및 연구 기관, 그리고 학술 기관입니다. EMB는 정확한 진단, 치료 계획, 이식 후 모니터링에 있어 심장학에서 매우 중요하며, 심장 생검 기기 시장에서 틈새 시장이지만 필수적인 부문을 반영합니다.
북미 심내막심근 생검 기기 시장은 미국, 캐나다, 멕시코로 구분됩니다. 첨단 심장 전달 시스템의 혁신, 규제 당국의 지원, 그리고 지속적인 규제 당국과의 협력은 북미 심내막심근 생검 기기 시장을 주도하고 있습니다. 이러한 기세의 좋은 예로 최근 BioCardia, Inc.의 움직임을 들 수 있습니다. 회사는 자사의 'Helix(TM) 경심내막 전달 카테터'에 대해 미국 식품의약국(FDA)으로부터 사전 제출 패키지를 승인받았습니다. 이번 승인은 정부 기관과의 지속적인 규제 당국과의 대화, 규제 프로세스의 효율화 및 당국과의 조기 협력을 통해 심내막심근 생검 기기의 개발이 가속화되고 있음을 보여줍니다. 2026년 3월 17일, BioCardia는 FDA가 의료기기 및 방사선보건센터(CDRH)와 생물학적 제제평가연구센터(CBER)와의 예비 협의를 거쳐 헬릭스 시스템의 사전 신청 패키지를 승인했다고 발표했습니다. CDRH와 CBER의 협력은 특히 생검 기반 치료법에서 의료기기와 생물학적 제제의 혁신이 지속적으로 융합되고 있음을 보여주며, CDRH는 CardiAMP 세포 치료제 혁신 지정의 지원을 받아 CBER과 협력 및 협의를 통해 심사를 주도하게 될 것입니다. 혁신 지정과 같은 의료 프로그램 및 신청 전 상담 프로그램을 활용하면 제조업체는 진단과 표적 치료를 심근 조직에 직접 시행하는 최소침습적 생검 기기 개발에 더 많은 확신을 가지고 투자할 수 있습니다. 이를 통해 새로운 기기의 시장 출시 과정을 가속화하고 북미 전역에 심내막심근 생검 기기의 보급을 촉진할 수 있을 것으로 기대됩니다.
진단과 치료 기능을 하나의 카테터 기반 시스템에 통합하는 움직임이 확대되고 있으며, Helix 시스템이 심근 내 전달 기능과 진단 기능을 모두 갖추고 있는 것도 그 중 하나입니다. 북미의 심혈관질환 발병률 증가와 정밀 의학에 대한 관심 증가로 인해 임상의들은 정확한 조직 샘플링과 심장 표적 부위에 표적 치료제를 전달할 수 있는 도구를 찾고 있습니다. 또한, 카테터 설계, 영상 유도 및 CardiAMP와 같은 세포 치료의 치료 능력은 심장에 대한 정확한 접근에 달려있습니다. 따라서 병원과 연구기관은 전통적인 외과적 개입에 따른 위험을 최소화하면서 환자에게 더 나은 치료를 제공하기 위해 이러한 기술을 더 자주 활용하고 있습니다. 규제 프로세스 개선, 기술 융합, 그리고 환자의 치료 접근성 향상에 대한 임상 현장의 수요 증가로 북미는 심내막심근 생검 기기 개발에서 선도적인 입지를 구축하고 있습니다.
목차
제1장 주요 요약
제2장 심내막심근 생검 기기 시장 전망
제3장 경쟁 구도
제4장 심내막심근 생검 기기 시장 : 주요 업계 역학
제5장 심내막심근 생검 기기 시장 : 세계 시장 분석
제6장 심내막심근 생검 기기 시장 매출 분석 : 제품 유형별
제7장 심내막심근 생검 기기 시장 매출 분석 : 가이드 기법별
제8장 심내막심근 생검 기기 시장 매출 분석 : 용도별
제9장 심내막심근 생검 기기 시장 매출 분석 : 최종사용자별
제10장 심내막심근 생검 기기 시장 : 지역별 분석
제11장 심내막심근 생검 기기 시장 업계 상황
제12장 심내막심근 생검 기기 시장 : 주요 기업 개요
제13장 기타 분석 대상 기업 리스트
제14장 부록
KSM 26.06.05According to our new research study on "Endomyocardial Biopsy Devices Market Forecast to 2034 -Global Analysis - by Product Type, Guidance Technique, Application, End User, and Geography," the market is anticipated to grow from US$ 352.25 million in 2025 to US$ 500.01 million by 2034, with a CAGR of 4.0% during 2026-2034. The endomyocardial biopsy devices market growth is attributed to the rising volume of heart transplant procedures, the rising prevalence of cardiovascular diseases (CVDs), and technological advancements in biopsy forceps and catheter design.
Endomyocardial biopsy (EMB) devices are used to obtain cardiac tissue samples, primarily for diagnosing myocarditis, cardiomyopathies, transplant rejection, and other cardiac pathologies. Key products include biopsy forceps, flexible catheters, and disposable or reusable designs, used with guidance systems like fluoroscopy, echocardiography, or emerging robotic navigation for precision. Accessories such as introducer sheaths, guidewires, and localization tools support the procedure. The primary end users are cardiac centers, hospitals, diagnostic and research institutes, and academic institutions. EMB is critical in cardiology for accurate diagnosis, treatment planning, and post-transplant monitoring, reflecting a niche yet essential segment of the cardiac biopsy devices market.
The endomyocardial biopsy devices market in North America is segmented into the US, Canada, and Mexico. Innovation in advanced cardiac delivery systems, regulatory support, and ongoing regulatory engagement are driving the endomyocardial biopsy devices market in North America. An example of this momentum is evident with recent developments from BioCardia, Inc., including the acceptance of a pre-submission package by the US Food and Drug Administration (FDA) for their Helix(TM) Transendocardial Delivery Catheter. This acceptance is indicative of how, through ongoing regulatory engagement with governmental agencies, streamlined regulatory pathways and early interaction with agencies, the development of endomyocardial biopsy devices is being accelerated. On March 17th, 2026, BioCardia announced that the FDA granted the pre-submission package for the Helix system after they had preliminary discussions with both the Center for Devices and Radiological Health (CDRH) and the Center for Biologics Evaluation and Research (CBER). The collaboration of CDRH & CBER represents the continued convergence between innovations in devices and biologics, especially in biopsy-guided therapies, and CDRH will lead the review in cooperation/consultation with CBER with the support of the CardiAMP Cell Therapy Breakthrough Designation. The use of healthcare programs such as breakthrough designations and the use of pre-submission consultation programs provides more certainty for manufacturers to invest in the development of minimally invasive biopsy devices that both diagnose and deliver targeted therapies directly to myocardial tissue, expediting the process of bringing new devices to market and facilitating the acceptance of endomyocardial biopsy devices throughout North America.
The combination of diagnostic and therapeutic capabilities into single catheter-based systems is expanding, including the fact that the Helix system has both intramyocardial delivery capabilities and diagnostic capabilities. The increasing incidence of cardiovascular disease in North America (along with the interest in precision medicine) has led clinicians to seek out tools that will allow accurate tissue sampling and delivery of targeted therapies to the targeted areas of the heart. In addition, catheter design, imaging guidance, and the ability to treat with cell-based therapies like CardiAMP depend upon being able to access the heart with precise accuracy; therefore, hospitals and research institutions are more frequently making use of these technologies to provide better care for patients while minimizing the risks associated with traditional surgical interventions. The development of regulatory processes, convergence of technologies, and growing demand within the clinical community for improved patient access to therapies are positioning North America as a leader in the development of endomyocardial biopsy devices.
The US Food and Drug Administration, International Society for Heart & Lung Transplantation, European Society of Cardiology are among the primary and secondary sources referred to while preparing the endomyocardial biopsy devices market report.
Table Of Contents
1. Executive Summary
- 1.1 Analyst Market Outlook
- 1.2 Market Attractiveness
2. Endomyocardial Biopsy Devices Market Landscape
- 2.1 Overview
- 2.2 Value Chain Analysis
- 2.2.1 Raw Materials/Components
- 2.2.2 Manufacturing Process/Technology
- 2.2.3 Distribution Landscape
- 2.2.4 End-User
- 2.2.5 Level of Integration
- 2.3 Supply Chain Analysis
- 2.3.1 List of Manufacturers/Suppliers
- 2.3.2 List of Potential Customers (Upto 50)
- 2.4 Porter's Five Force Analysis
- 2.5 PEST Analysis
- 2.6 Import-Export Analysis for Key Countries (As per the nearest HS Code)
- 2.6.1 Import-Export Analysis for Key Countries, 2025
- 2.7 Impact of Artificial Intelligence (AI)
- 2.8 Product or Technology Roadmap
- 2.9 Sustainability and ESG Trends
- 2.10 Patent Analysis
- 2.11 Regulatory Framework
3. Competitive Landscape
- 3.1 Company Benchmarking by Key Players
- 3.2 Market Share Analysis, 2025 - By Key Players
- 3.3 Market Concentration
4. Endomyocardial Biopsy Devices Market - Key Industry Dynamics
- 4.1 Market Drivers
- 4.1.1 Rising Volume of Heart Transplant Procedures Globally
- 4.1.2 Growing Prevalence of Cardiovascular Diseases (CVDs)
- 4.1.3 Technological Advancements in Biopsy Forceps and Catheter Design
- 4.2 Market Restraints
- 4.2.1 Shortage of Skilled Cardiologists Trained in Biopsy Procedures
- 4.2.2 Risk of Complications Such as Cardiac Perforation and Arrhythmias
- 4.2.3 Stringent Regulatory Approval Processes Delaying Product Commercialization
- 4.3 Market Opportunities
- 4.3.1 Expansion of Cardiac Specialty Hospitals and Catheterization Labs
- 4.3.2 Increasing Clinical Trials and Research
- 4.3.3 Collaborations Between Device Manufacturers and Cardiac Centers
- 4.4 Future Trends
- 4.4.1 AI-Driven Precision and Minimally Invasive Innovations
- 4.4.2 Miniaturization of Endomyocardial Biopsy Devices
- 4.4.3 Integration of Molecular Diagnostics and Biomarker Testing with Biopsy Samples
- 4.5 Impact of Drivers and Restraints
5. Endomyocardial Biopsy Devices Market - Global Market Analysis
- 5.1 Endomyocardial Biopsy Devices Market Revenue (US$ Thousand), 2021-2034
- 5.2 Endomyocardial Biopsy Devices Market Forecast and Analysis
6. Endomyocardial Biopsy Devices Market Revenue Analysis - Product Type
- 6.1 Endomyocardial Biopsy Devices Market Forecasts and Analysis by Product Type
- 6.1.1 Biopsy Forceps and Catheters
- 6.1.1.1 Overview
- 6.1.1.2 Biopsy Forceps and Catheters: Endomyocardial Biopsy Devices Market - Revenue, 2021-2034 (US$ Thousand)
- 6.1.2 Guidance Systems
- 6.1.2.1 Overview
- 6.1.2.2 Guidance Systems: Endomyocardial Biopsy Devices Market - Revenue, 2021-2034 (US$ Thousand)
- 6.1.3 Accessories
- 6.1.3.1 Overview
- 6.1.3.2 Accessories: Endomyocardial Biopsy Devices Market - Revenue, 2021-2034 (US$ Thousand)
- 6.1.1 Biopsy Forceps and Catheters
7. Endomyocardial Biopsy Devices Market Revenue Analysis - Guidance Technique
- 7.1 Endomyocardial Biopsy Devices Market Forecasts and Analysis by Guidance Technique
- 7.1.1 Fluoroscopy-guided EMB
- 7.1.1.1 Overview
- 7.1.1.2 Fluoroscopy-guided EMB: Endomyocardial Biopsy Devices Market - Revenue, 2021-2034 (US$ Thousand)
- 7.1.2 Echocardiography-guided EMB
- 7.1.2.1 Overview
- 7.1.2.2 Echocardiography-guided EMB: Endomyocardial Biopsy Devices Market - Revenue, 2021-2034 (US$ Thousand)
- 7.1.3 Hybrid techniques
- 7.1.3.1 Overview
- 7.1.3.2 Hybrid techniques: Endomyocardial Biopsy Devices Market - Revenue, 2021-2034 (US$ Thousand)
- 7.1.1 Fluoroscopy-guided EMB
8. Endomyocardial Biopsy Devices Market Revenue Analysis - Application
- 8.1 Endomyocardial Biopsy Devices Market Forecasts and Analysis by Application
- 8.1.1 Transplant rejection monitoring
- 8.1.1.1 Overview
- 8.1.1.2 Transplant rejection monitoring: Endomyocardial Biopsy Devices Market - Revenue, 2021-2034 (US$ Thousand)
- 8.1.2 Myocarditis diagnosis
- 8.1.2.1 Overview
- 8.1.2.2 Myocarditis diagnosis: Endomyocardial Biopsy Devices Market - Revenue, 2021-2034 (US$ Thousand)
- 8.1.3 Cardiomyopathy evaluation
- 8.1.3.1 Overview
- 8.1.3.2 Cardiomyopathy evaluation: Endomyocardial Biopsy Devices Market - Revenue, 2021-2034 (US$ Thousand)
- 8.1.4 Other cardiac pathologies
- 8.1.4.1 Overview
- 8.1.4.2 Other cardiac pathologies: Endomyocardial Biopsy Devices Market - Revenue, 2021-2034 (US$ Thousand)
- 8.1.1 Transplant rejection monitoring
9. Endomyocardial Biopsy Devices Market Revenue Analysis - End User
- 9.1 Endomyocardial Biopsy Devices Market Forecasts and Analysis by End User
- 9.1.1 Cardiac centers and hospitals
- 9.1.1.1 Overview
- 9.1.1.2 Cardiac centers and hospitals: Endomyocardial Biopsy Devices Market - Revenue, 2021-2034 (US$ Thousand)
- 9.1.2 Diagnostic and research institutes
- 9.1.2.1 Overview
- 9.1.2.2 Diagnostic and research institutes: Endomyocardial Biopsy Devices Market - Revenue, 2021-2034 (US$ Thousand)
- 9.1.3 Academic institutions
- 9.1.3.1 Overview
- 9.1.3.2 Academic institutions: Endomyocardial Biopsy Devices Market - Revenue, 2021-2034 (US$ Thousand)
- 9.1.1 Cardiac centers and hospitals
10. Endomyocardial Biopsy Devices Market - Geographical Analysis
- 10.1 North America
- 10.1.1 North America Endomyocardial Biopsy Devices Market Overview
- 10.1.2 North America: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.1.3 North America: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.1.3.1. Product Type
- 10.1.3.1.1 Biopsy Forceps And Catheters
- 10.1.3.1.2 Guidance Systems
- 10.1.3.1.3 Accessories
- 10.1.3.2. Guidance Technique
- 10.1.3.3. Application
- 10.1.3.4. End User
- 10.1.3.1. Product Type
- 10.1.4 North America: Endomyocardial Biopsy Devices Market Breakdown by Countries
- 10.1.4.1. United States Market
- 10.1.4.1.1 United States: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.1.4.1.2 United States: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.1.4.1.2.1 Product Type
- 10.1.4.1.2.1.1 Biopsy Forceps And Catheters
- 10.1.4.1.2.1.2 Guidance Systems
- 10.1.4.1.2.1.3 Accessories
- 10.1.4.1.2.2 Guidance Technique
- 10.1.4.1.2.3 Application
- 10.1.4.1.2.4 End User
- 10.1.4.1.2.1 Product Type
- 10.1.4.2. Canada Market
- 10.1.4.2.1 Canada: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.1.4.2.2 Canada: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.1.4.2.2.1 Product Type
- 10.1.4.2.2.1.1 Biopsy Forceps And Catheters
- 10.1.4.2.2.1.2 Guidance Systems
- 10.1.4.2.2.1.3 Accessories
- 10.1.4.2.2.2 Guidance Technique
- 10.1.4.2.2.3 Application
- 10.1.4.2.2.4 End User
- 10.1.4.2.2.1 Product Type
- 10.1.4.3. Mexico Market
- 10.1.4.3.1 Mexico: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.1.4.3.2 Mexico: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.1.4.3.2.1 Product Type
- 10.1.4.3.2.1.1 Biopsy Forceps And Catheters
- 10.1.4.3.2.1.2 Guidance Systems
- 10.1.4.3.2.1.3 Accessories
- 10.1.4.3.2.2 Guidance Technique
- 10.1.4.3.2.3 Application
- 10.1.4.3.2.4 End User
- 10.1.4.3.2.1 Product Type
- 10.1.4.1. United States Market
- 10.2 Europe
- 10.2.1 Europe Endomyocardial Biopsy Devices Market Overview
- 10.2.2 Europe: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.2.3 Europe: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.2.3.1. Product Type
- 10.2.3.1.1 Biopsy Forceps And Catheters
- 10.2.3.1.2 Guidance Systems
- 10.2.3.1.3 Accessories
- 10.2.3.2. Guidance Technique
- 10.2.3.3. Application
- 10.2.3.4. End User
- 10.2.3.1. Product Type
- 10.2.4 Europe: Endomyocardial Biopsy Devices Market Breakdown by Countries
- 10.2.4.1. Germany Market
- 10.2.4.1.1 Germany: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.2.4.1.2 Germany: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.2.4.1.2.1 Product Type
- 10.2.4.1.2.1.1 Biopsy Forceps And Catheters
- 10.2.4.1.2.1.2 Guidance Systems
- 10.2.4.1.2.1.3 Accessories
- 10.2.4.1.2.2 Guidance Technique
- 10.2.4.1.2.3 Application
- 10.2.4.1.2.4 End User
- 10.2.4.1.2.1 Product Type
- 10.2.4.2. United Kingdom Market
- 10.2.4.2.1 United Kingdom: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.2.4.2.2 United Kingdom: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.2.4.2.2.1 Product Type
- 10.2.4.2.2.1.1 Biopsy Forceps And Catheters
- 10.2.4.2.2.1.2 Guidance Systems
- 10.2.4.2.2.1.3 Accessories
- 10.2.4.2.2.2 Guidance Technique
- 10.2.4.2.2.3 Application
- 10.2.4.2.2.4 End User
- 10.2.4.2.2.1 Product Type
- 10.2.4.3. France Market
- 10.2.4.3.1 France: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.2.4.3.2 France: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.2.4.3.2.1 Product Type
- 10.2.4.3.2.1.1 Biopsy Forceps And Catheters
- 10.2.4.3.2.1.2 Guidance Systems
- 10.2.4.3.2.1.3 Accessories
- 10.2.4.3.2.2 Guidance Technique
- 10.2.4.3.2.3 Application
- 10.2.4.3.2.4 End User
- 10.2.4.3.2.1 Product Type
- 10.2.4.4. Italy Market
- 10.2.4.4.1 Italy: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.2.4.4.2 Italy: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.2.4.4.2.1 Product Type
- 10.2.4.4.2.1.1 Biopsy Forceps And Catheters
- 10.2.4.4.2.1.2 Guidance Systems
- 10.2.4.4.2.1.3 Accessories
- 10.2.4.4.2.2 Guidance Technique
- 10.2.4.4.2.3 Application
- 10.2.4.4.2.4 End User
- 10.2.4.4.2.1 Product Type
- 10.2.4.5. Spain Market
- 10.2.4.5.1 Spain: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.2.4.5.2 Spain: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.2.4.5.2.1 Product Type
- 10.2.4.5.2.1.1 Biopsy Forceps And Catheters
- 10.2.4.5.2.1.2 Guidance Systems
- 10.2.4.5.2.1.3 Accessories
- 10.2.4.5.2.2 Guidance Technique
- 10.2.4.5.2.3 Application
- 10.2.4.5.2.4 End User
- 10.2.4.5.2.1 Product Type
- 10.2.4.6. Rest of Europe Market
- 10.2.4.6.1 Rest of Europe: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.2.4.6.2 Rest of Europe: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.2.4.6.2.1 Product Type
- 10.2.4.6.2.1.1 Biopsy Forceps And Catheters
- 10.2.4.6.2.1.2 Guidance Systems
- 10.2.4.6.2.1.3 Accessories
- 10.2.4.6.2.2 Guidance Technique
- 10.2.4.6.2.3 Application
- 10.2.4.6.2.4 End User
- 10.2.4.6.2.1 Product Type
- 10.2.4.1. Germany Market
- 10.3 Asia Pacific
- 10.3.1 Asia Pacific Endomyocardial Biopsy Devices Market Overview
- 10.3.2 Asia Pacific: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.3.3 Asia Pacific: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.3.3.1. Product Type
- 10.3.3.1.1 Biopsy Forceps And Catheters
- 10.3.3.1.2 Guidance Systems
- 10.3.3.1.3 Accessories
- 10.3.3.2. Guidance Technique
- 10.3.3.3. Application
- 10.3.3.4. End User
- 10.3.3.1. Product Type
- 10.3.4 Asia Pacific: Endomyocardial Biopsy Devices Market Breakdown by Countries
- 10.3.4.1. China Market
- 10.3.4.1.1 China: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.3.4.1.2 China: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.3.4.1.2.1 Product Type
- 10.3.4.1.2.1.1 Biopsy Forceps And Catheters
- 10.3.4.1.2.1.2 Guidance Systems
- 10.3.4.1.2.1.3 Accessories
- 10.3.4.1.2.2 Guidance Technique
- 10.3.4.1.2.3 Application
- 10.3.4.1.2.4 End User
- 10.3.4.1.2.1 Product Type
- 10.3.4.2. Japan Market
- 10.3.4.2.1 Japan: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.3.4.2.2 Japan: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.3.4.2.2.1 Product Type
- 10.3.4.2.2.1.1 Biopsy Forceps And Catheters
- 10.3.4.2.2.1.2 Guidance Systems
- 10.3.4.2.2.1.3 Accessories
- 10.3.4.2.2.2 Guidance Technique
- 10.3.4.2.2.3 Application
- 10.3.4.2.2.4 End User
- 10.3.4.2.2.1 Product Type
- 10.3.4.3. India Market
- 10.3.4.3.1 India: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.3.4.3.2 India: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.3.4.3.2.1 Product Type
- 10.3.4.3.2.1.1 Biopsy Forceps And Catheters
- 10.3.4.3.2.1.2 Guidance Systems
- 10.3.4.3.2.1.3 Accessories
- 10.3.4.3.2.2 Guidance Technique
- 10.3.4.3.2.3 Application
- 10.3.4.3.2.4 End User
- 10.3.4.3.2.1 Product Type
- 10.3.4.4. Australia Market
- 10.3.4.4.1 Australia: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.3.4.4.2 Australia: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.3.4.4.2.1 Product Type
- 10.3.4.4.2.1.1 Biopsy Forceps And Catheters
- 10.3.4.4.2.1.2 Guidance Systems
- 10.3.4.4.2.1.3 Accessories
- 10.3.4.4.2.2 Guidance Technique
- 10.3.4.4.2.3 Application
- 10.3.4.4.2.4 End User
- 10.3.4.4.2.1 Product Type
- 10.3.4.5. South Korea Market
- 10.3.4.5.1 South Korea: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.3.4.5.2 South Korea: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.3.4.5.2.1 Product Type
- 10.3.4.5.2.1.1 Biopsy Forceps And Catheters
- 10.3.4.5.2.1.2 Guidance Systems
- 10.3.4.5.2.1.3 Accessories
- 10.3.4.5.2.2 Guidance Technique
- 10.3.4.5.2.3 Application
- 10.3.4.5.2.4 End User
- 10.3.4.5.2.1 Product Type
- 10.3.4.6. Rest of Asia Pacific Market
- 10.3.4.6.1 Rest of Asia Pacific: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.3.4.6.2 Rest of Asia Pacific: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.3.4.6.2.1 Product Type
- 10.3.4.6.2.1.1 Biopsy Forceps And Catheters
- 10.3.4.6.2.1.2 Guidance Systems
- 10.3.4.6.2.1.3 Accessories
- 10.3.4.6.2.2 Guidance Technique
- 10.3.4.6.2.3 Application
- 10.3.4.6.2.4 End User
- 10.3.4.6.2.1 Product Type
- 10.3.4.1. China Market
- 10.4 Middle East and Africa
- 10.4.1 Middle East and Africa Endomyocardial Biopsy Devices Market Overview
- 10.4.2 Middle East and Africa: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.4.3 Middle East and Africa: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.4.3.1. Product Type
- 10.4.3.1.1 Biopsy Forceps And Catheters
- 10.4.3.1.2 Guidance Systems
- 10.4.3.1.3 Accessories
- 10.4.3.2. Guidance Technique
- 10.4.3.3. Application
- 10.4.3.4. End User
- 10.4.3.1. Product Type
- 10.4.4 Middle East and Africa: Endomyocardial Biopsy Devices Market Breakdown by Countries
- 10.4.4.1. Saudi Arabia Market
- 10.4.4.1.1 Saudi Arabia: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.4.4.1.2 Saudi Arabia: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.4.4.1.2.1 Product Type
- 10.4.4.1.2.1.1 Biopsy Forceps And Catheters
- 10.4.4.1.2.1.2 Guidance Systems
- 10.4.4.1.2.1.3 Accessories
- 10.4.4.1.2.2 Guidance Technique
- 10.4.4.1.2.3 Application
- 10.4.4.1.2.4 End User
- 10.4.4.1.2.1 Product Type
- 10.4.4.2. South Africa Market
- 10.4.4.2.1 South Africa: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.4.4.2.2 South Africa: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.4.4.2.2.1 Product Type
- 10.4.4.2.2.1.1 Biopsy Forceps And Catheters
- 10.4.4.2.2.1.2 Guidance Systems
- 10.4.4.2.2.1.3 Accessories
- 10.4.4.2.2.2 Guidance Technique
- 10.4.4.2.2.3 Application
- 10.4.4.2.2.4 End User
- 10.4.4.2.2.1 Product Type
- 10.4.4.3. United Arab Emirates Market
- 10.4.4.3.1 United Arab Emirates: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.4.4.3.2 United Arab Emirates: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.4.4.3.2.1 Product Type
- 10.4.4.3.2.1.1 Biopsy Forceps And Catheters
- 10.4.4.3.2.1.2 Guidance Systems
- 10.4.4.3.2.1.3 Accessories
- 10.4.4.3.2.2 Guidance Technique
- 10.4.4.3.2.3 Application
- 10.4.4.3.2.4 End User
- 10.4.4.3.2.1 Product Type
- 10.4.4.4. Rest of Middle East and Africa Market
- 10.4.4.4.1 Rest of Middle East and Africa: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.4.4.4.2 Rest of Middle East and Africa: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.4.4.4.2.1 Product Type
- 10.4.4.4.2.1.1 Biopsy Forceps And Catheters
- 10.4.4.4.2.1.2 Guidance Systems
- 10.4.4.4.2.1.3 Accessories
- 10.4.4.4.2.2 Guidance Technique
- 10.4.4.4.2.3 Application
- 10.4.4.4.2.4 End User
- 10.4.4.4.2.1 Product Type
- 10.4.4.1. Saudi Arabia Market
- 10.5 South and Central America
- 10.5.1 South and Central America Endomyocardial Biopsy Devices Market Overview
- 10.5.2 South and Central America: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.5.3 South and Central America: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.5.3.1. Product Type
- 10.5.3.1.1 Biopsy Forceps And Catheters
- 10.5.3.1.2 Guidance Systems
- 10.5.3.1.3 Accessories
- 10.5.3.2. Guidance Technique
- 10.5.3.3. Application
- 10.5.3.4. End User
- 10.5.3.1. Product Type
- 10.5.4 South and Central America: Endomyocardial Biopsy Devices Market Breakdown by Countries
- 10.5.4.1. Brazil Market
- 10.5.4.1.1 Brazil: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.5.4.1.2 Brazil: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.5.4.1.2.1 Product Type
- 10.5.4.1.2.1.1 Biopsy Forceps And Catheters
- 10.5.4.1.2.1.2 Guidance Systems
- 10.5.4.1.2.1.3 Accessories
- 10.5.4.1.2.2 Guidance Technique
- 10.5.4.1.2.3 Application
- 10.5.4.1.2.4 End User
- 10.5.4.1.2.1 Product Type
- 10.5.4.2. Argentina Market
- 10.5.4.2.1 Argentina: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.5.4.2.2 Argentina: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.5.4.2.2.1 Product Type
- 10.5.4.2.2.1.1 Biopsy Forceps And Catheters
- 10.5.4.2.2.1.2 Guidance Systems
- 10.5.4.2.2.1.3 Accessories
- 10.5.4.2.2.2 Guidance Technique
- 10.5.4.2.2.3 Application
- 10.5.4.2.2.4 End User
- 10.5.4.2.2.1 Product Type
- 10.5.4.3. Rest of South and Central America Market
- 10.5.4.3.1 Rest of South and Central America: Endomyocardial Biopsy Devices Market Revenue and Forecasts, 2021-2034 (US$ Thousand)
- 10.5.4.3.2 Rest of South and Central America: Endomyocardial Biopsy Devices Market - By Segmentation
- 10.5.4.3.2.1 Product Type
- 10.5.4.3.2.1.1 Biopsy Forceps And Catheters
- 10.5.4.3.2.1.2 Guidance Systems
- 10.5.4.3.2.1.3 Accessories
- 10.5.4.3.2.2 Guidance Technique
- 10.5.4.3.2.3 Application
- 10.5.4.3.2.4 End User
- 10.5.4.3.2.1 Product Type
- 10.5.4.1. Brazil Market
11. Endomyocardial Biopsy Devices Market Industry Landscape
12. Endomyocardial Biopsy Devices Market - Key Company Profiles
- 12.1 Argon Medical Devices
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
- 12.2 Cordis Corp
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
- 12.3 Scholten Surgical Instruments, Inc.
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
- 12.4 Changzhou Lookmed Medical Instrument Co., Ltd.
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
- 12.5 FEHLING INSTRUMENTS GmbH
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
- 12.6 WILDmedical GmbH
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
- 12.7 Terumo Corp
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
- 12.8 Siemens Healthineers AG
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
- 12.9 Koninklijke Philips NV
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
- 12.10 GE HealthCare Technologies Inc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. List of Additional Companies Analyzed
- 13.1 List of Additional Companies Analyzed
14. Appendix
- 14.1 Glossary
- 14.2 Research Methodology and Approach
- 14.2.1 Secondary Research
- 14.2.2 Primary Research
- 14.2.3 Market Estimation Approach
- 14.2.3.1. Supply Side Analysis
- 14.2.3.2. Demand Side Analysis
- 14.2.4 Research Assumptions and Limitations
- 14.2.5 Currency Conversion
- 14.3 About The Insight Partners
- 14.4 Market Intelligence Cloud
